Showing results (191-200 of 234) with videos related to

Sort By:
Pageof 24
Tumori|July 6, 2018
Multidisciplinary teams for the proper management of patients with genitourinary tumors: When topics set scientific societies' agendaTiziana Magnani, Sergio Bracarda, Rolando M D'Angelillo, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2011
Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) studyCesare Gridelli, Andrea Ardizzoni, Sandro Barni, et al.
Tumori|February 11, 2012
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic reviewMario Airoldi, Dino Amadori, Sandro Barni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2014
Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patientsCesare Gridelli, Silvia Novello, Nicoletta Zilembo, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 30, 2022
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trialGerardo Rosati, Chiara Alessandra Cella, Luigi Cavanna, et al.
Plos One|May 26, 2016
Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC StudyStefania Gori, Alessandro Inno, Valentina Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2018
FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant TrialAlberto Sobrero, Sara Lonardi, Gerardo Rosati, et al.
Clinical Breast Cancer|June 18, 2019
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast CancerStefania Gori, Fabio Puglisi, Stefano Moroso, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2016
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studiesMatteo Lambertini, Marcello Ceppi, Francesco Cognetti, et al.
Haematologica|September 28, 2019
Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancerCinzia Giaccherini, Marina Marchetti, Giovanna Masci, et al.
Pageof 24